Home › Lymphoma › Alabama › Birmingham

Pag-aaral pangklinika para sa Lymphoma sa Birmingham, AL

Isang pag-aaral para sa Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Birmingham. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

Nagre-recruitPhase 1/2

Children's Hospital of Alabama, Birmingham

12 Months – 21 Years · Lahat ng kasarian · Na-update Set 11, 2026 · NCT04870944

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

Nagre-recruitPhase 1/2

O'Neal Comprehensive Cancer Center, University of Alabama, Birmingham

Edad 12 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT04588922

DALY II USA/ MB-CART2019.1 for DLBCL

Nagre-recruitPhase 2

University of Alabama at Birmingham, Birmingham

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT04792489

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

Nagre-recruitPhase 1/2

Dren Investigational Site, Birmingham

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 17, 2026 · NCT05475925

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Nagre-recruitObservasyonal na pag-aaral

Children's Hospital of Alabama, Birmingham

Lahat ng edad · Lahat ng kasarian · Na-update May 18, 2026 · NCT01790152

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Nagre-recruitPhase 2

University of Alabama Birmingham, Birmingham

Edad 18 hanggang 66 · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT06859424

Describing Treatment Outcomes and Responses in Lymphoma-associated Hemophagocytic Lymphohistiocytosis

Nagre-recruitObservasyonal na pag-aaral

University of Alabama at Birmingham, Birmingham

Lahat ng edad · Lahat ng kasarian · Na-update Ene 22, 2026 · NCT05898477

HPC Offered for PRESERVE Expansion

Nagre-recruitObservasyonal na pag-aaral

University of Alabama, Birmingham, Birmingham

Edad 12 hanggang 80 · Lahat ng kasarian · Na-update Ago 28, 2025 · NCT07145411

Pag-aaral para sa Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Birmingham

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.